Debra Zack
Net worth: 174 135 $ as of 2024-03-30
Profile
Debra Jeske Zack worked as an Executive Director-Global Product Area at Amgen, Inc. and as a Vice President-Clinical Development at Xencor, Inc. Prior to that, she was an Associate Professor at the University of California, Los Angeles.
She also served as the Chief Medical Officer at Exagen, Inc. from 2020 to 2022.
Dr. Zack received her undergraduate degree from Texas Christian University and her doctorate from The University of Texas Southwestern Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXAGEN, INC.
0.64% | 2023-04-17 | 109,519 ( 0.64% ) | 174 135 $ | 2024-03-30 |
Former positions of Debra Zack
| Companies | Position | End |
|---|---|---|
| EXAGEN INC. | Chief Tech/Sci/R&D Officer | 2022-12-04 |
| University of California, Los Angeles | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| XENCOR, INC. | Corporate Officer/Principal | - |
Training of Debra Zack
| Texas Christian University | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| EXAGEN INC. | Health Services |
- Stock Market
- Insiders
- Debra Zack
